SCHEMBL448348

SCHEMBL448348

c1ccc(C(c2ccccc2)C(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.53
F2 P00734 1/20 0.53
TSHR P16473 1/20 0.53
HTR2A P28223 1/20 0.47
TAAR1 Q96RJ0 1/20 0.47
CYP2D6 P10635 1/20 0.45
SRC P12931 1/20 0.45
LMNA P02545 2/20 0.43
HRH1 P35367 1/20 0.43
MTOR P42345 1/20 0.43
RAB9A P51151 1/20 0.43
GRM7 Q14831 1/20 0.43
MAPK1 P28482 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28346122 0.96 DPP4 (0.50) DPP4F2TSHRHTR2ATAAR1
SCHEMBL17923689 0.82 LMNA (0.53) TSHRLMNACES2CES1
SCHEMBL29004504 0.82 CYP3A4 (0.67) DPP4F2TSHRHTR2ATAAR1
SCHEMBL14163315 0.82 IDO1 (0.56) LMNAMTORRAB9ACES2
SCHEMBL17995329 0.82 IDO1 (0.56) LMNAMTORRAB9ACES2
SCHEMBL29156517 0.82 TSHR (0.46) DPP4F2TSHRHTR2ATAAR1
SCHEMBL12199145 0.82 LMNA (0.53) TSHRLMNACES2CES1
SCHEMBL503028 0.82 IDO1 (0.56) LMNAMTORRAB9ACES2
SCHEMBL22129264 0.82 DPP4 (0.39) DPP4F2TSHRHTR2ATAAR1
SCHEMBL6745618 0.79 DPP4 (0.58) DPP4F2HTR2ATAAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 468 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240384025-A1 A THERMALLY CURABLE EPOXY SYSTEM ADITYA BIRLA CHEMICALS (THAILAND) LIMITED (ADVANCED MATERIALS) (TH) 2024-11-21 US claimed
EP-4347712-A1 A THERMALLY CURABLE EPOXY SYSTEM Aditya Birla Chemicals (Thailand) Ltd. (Advanced Materials) (TH) 2024-04-10 EP claimed
WO-2022254329-A1 A THERMALLY CURABLE EPOXY SYSTEM ADITYA BIRLA CHEMICALS (THAILAND) LIMITED (ADVANCED MATERIALS) (TH) 2022-12-08 WO claimed
CN-114950159-A Preparation method of aromatic polymer separation membrane based on super-acid catalysis preparation 南京工业大学 2022-08-30 CN claimed
US-20200331934-A1 PREPARATION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP KOREA INST IND TECH (KR) 2020-10-22 US claimed
US-10689482-B2 Epoxy compound having alkoxysilyl group, composition and hardened material comprising same, use for same, and production method for epoxy compound having alkoxysilyl group KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2020-06-23 US claimed
CN-106103532-B Phenolic novolak hardener containing alkoxysilyl group, process for producing the same, composition containing the same, hardened product and use thereof 韩国生产技术研究院 2018-10-02 CN claimed
CN-105073760-B Epoxide with alkoxysilyl groups, preparation method include its composition and cured product, and application thereof 韩国生产技术研究院 2018-06-12 CN claimed
EP-2774929-B1 ISOCYANURATE EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, METHOD OF PREPARING SAME, COMPOSITION INCLUDING SAME, CURED PRODUCT OF THE COMPOSITION, AND USE OF THE COMPOSITION KOREA IND TECH INST (KR) 2017-03-08 EP claimed
US-9534075-B2 Isocyanurate epoxy compound having alkoxysilyl group, method of preparing same, composition including same, cured product of the composition, and use of the composition KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2017-01-03 US claimed
CN-103889977-A Epoxy compound having alkoxysilyl group, method for producing same, composition and cured material comprising same, and use thereof KOREA IND TECH INST 2014-06-25 CN claimed
US-7569599-B2 Intermediates for the production of optically active cyclopropylamine derivatives and process for the production of the intermediates DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-08-04 US claimed
US-20080233438-A1 Fuel for fuel cell, fuel cell and application thereof KURITA WATER INDUSTRIES LTD. (JP) 2008-09-25 US claimed
US-7220294-B2 Forming ambient pressure and temperature, lightweight, transportable power source; contacting gas with organic compound in pressurized state KURITA WATER INDUSTRIES LTD. (JP) 2007-05-22 US claimed
US-7211683-B2 Process for preparing organosilanes WACKER CHEMIE AG (DE) 2007-05-01 US claimed
CN-1894818-A Fuel for fuel cell, fuel cell and use thereof KURITA WATER IND LTD (JP) 2007-01-10 CN claimed
EP-1705740-A1 FUEL FOR FUEL CELL, FUEL CELL AND APPLICATION THEREOF Kurita Water Industries Ltd. (JP) 2006-09-27 EP claimed
CN-1659174-A Hydrogen storage method, hydrogen clathrate and process for producing the same KURITA WATER IND LTD (JP) 2005-08-24 CN claimed
US-20040230084-A1 Forming ambient pressure and temperature, lightweight, transportable power source; contacting gas with organic compound in pressurized state KURITA WATER INDUSTRIES LTD. (JP) 2004-11-18 US claimed
EP-1428831-A1 METHOD OF STORING HYDROGEN, HYDROGEN INCLUSION COMPOUND AND PROCESS FOR PRODUCING THE SAME KURITA WATER INDUSTRIES LTD. (JP) 2004-06-16 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10689482-B2 Epoxy compound having alkoxysilyl group, composition and hardened material comprising same, use for same, and production method for epoxy compound having alkoxysilyl group ESD, ELL, ASH2L DPP4 4765/4885F2 4122/4885TSHR 3894/4885
US-20200331934-A1 PREPARATION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP ALK, ALKBH3, PHOSPHO1 DPP4 4311/4885F2 269/4885TSHR 3978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.